Loading stock data…
$1.33-0.04 (-2.92%)
Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications.
Dermata Therapeutics, Inc. in the Healthcare sector is trading at $1.33. The stock is currently near its 52-week low of $1.10, remaining 59.3% below its 200-day moving average. Technical signals show neutral RSI of 53 and bullish MACD crossover, explaining why DRMA maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its lead product ca...